Pages that link to "Q34288506"
Jump to navigation
Jump to search
The following pages link to Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement (Q34288506):
Displaying 50 items.
- Screening for prostate cancer (Q24201690) (← links)
- Current status of biomarkers for prostate cancer (Q24600574) (← links)
- Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer (Q26739708) (← links)
- Limitations and Prospects for Diffusion-Weighted MRI of the Prostate (Q26744802) (← links)
- Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review (Q26748872) (← links)
- Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review (Q26748873) (← links)
- The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements (Q26750672) (← links)
- Testosterone Replacement Therapy and Prostate Cancer Incidence (Q26771774) (← links)
- Active surveillance and focal therapy for low-intermediate risk prostate cancer (Q26773641) (← links)
- Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer (Q26776478) (← links)
- Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis (Q26781093) (← links)
- Obesity and cancer: mechanistic insights from transdisciplinary studies (Q26786829) (← links)
- Immune Infiltration and Prostate Cancer (Q26798412) (← links)
- What is lacking in current decision aids on cancer screening? (Q26822925) (← links)
- Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors (Q26858959) (← links)
- A conceptual model of the multiple stages of communication necessary to support patient-centered care (Q26861619) (← links)
- Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening (Q26864419) (← links)
- Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles (Q26865810) (← links)
- Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening (Q27001043) (← links)
- Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel (Q27001399) (← links)
- Screening guidelines for non-AIDS defining cancers in HIV-infected individuals (Q27021899) (← links)
- The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making (Q27025062) (← links)
- Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening (Q27025805) (← links)
- Biomarkers in prostate cancer: what's new? (Q27026210) (← links)
- Health literacy and cancer screening: a systematic review (Q27026793) (← links)
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. (Q27300459) (← links)
- Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort (Q27308897) (← links)
- The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. (Q27311513) (← links)
- The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening (Q27314872) (← links)
- Prostate cancer screening in Brazil: should it be done or not? (Q28068688) (← links)
- The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance (Q28076745) (← links)
- How Precisely Can Prostate Cancer Be Managed? (Q28078942) (← links)
- Prostate cancer in Brazil and Latin America: epidemiology and screening (Q28079012) (← links)
- Current role of multiparametric magnetic resonance imaging in the management of prostate cancer (Q28082035) (← links)
- Impact of Age and Comorbidity on Cervical and Breast Cancer Literacy of African Americans, Latina, and Arab Women (Q28082544) (← links)
- Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population (Q28384774) (← links)
- Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells (Q28533234) (← links)
- Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells (Q28547040) (← links)
- A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer (Q28652628) (← links)
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study (Q29030107) (← links)
- The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. (Q30239973) (← links)
- CCAFU french national guidelines 2016-2018 on prostate cancer (Q30241244) (← links)
- Population-based screening for cancer: hope and hype. (Q30251601) (← links)
- Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation (Q30393331) (← links)
- Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan. (Q30399140) (← links)
- Quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients (Q30417067) (← links)
- Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective (Q30422070) (← links)
- Transrectal electrical impedance tomography of the prostate: spatially coregistered pathological findings for prostate cancer detection. (Q30437659) (← links)
- Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials (Q30536703) (← links)
- Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study (Q30543371) (← links)